• 迷你书屋,让阅读无处不在 2019-09-24
  • 紫光阁中共中央国家机关工作委员会 2019-09-24
  • 三星A6A6+曝光:搭载Exynos 7870+安卓8.0系统 2019-08-27
  • 人民的需要与发展的不平衡的矛盾,社会主义追求公平正义的要求与现有的发展方式、分配方式的矛 盾不断加大,必须用马克思主义政治经济学来研究解决。 2019-08-27
  • 古天乐力压刘德华 首度斩获香港电影金像奖最佳男主角 2019-08-22
  • 神奇!这种纸能千年不腐 默默记录西藏 2019-08-19
  • 世界杯冷门为何这么多? 2019-08-19
  • 对话王菊:别人谈论的王菊,是不是真实的我? 2019-08-15
  • [微笑]正是因为土地是属于全民的,你个人要使用就必须付钱,不然就占了大家的便宜。 2019-08-15
  •  
    Home    Contact us    中文
    SZ&W >  Industry >  Biopharma & IVD
     
             
    Nuclear Power
    Solar & Renewable
    Offshore & Marine
    Biopharma & IVD
    Oil & Gas
    Unconventional Gas
    Telecom & Media
    Transport & Logistic
    Finance & Investment
    Life Science
    Real Estate
    Retail & Entertainment
    Aerospace & Defense
    Power & Utilities
    Hospitality
    FinTrends
    Insurance
    Autonomous Vehicle
    New Energy Vehicle
    Automotive Lightweight
     
    Biopharma & IVD
     

    The global in vitro diagnostics market is forecast to grow from $53.3 billion in 2013 to $69.3 billion by the year 2018, according to EAC, predicted 4.9% annual growth assuming constant currency rates.

    By region, North America is the largest IVD market at $23.4 billion in 2013, followed by Europe/Middle East/Africa at $18.8 billion, Asia-Pacific at $5.9 billion, Japan at $3.9 billion and Latin America at $2.5 billion. But Asia-Pacific is the fastest growing region with continued double digit growth rates.

    By segment, 5 largest segments, in rank order, are Immunoassays, Whole Blood Glucose, Central Lab Clinical Chemistry, POC/POL and Clinical Molecular. However, the fastest growing segments in the past year were Clinical Molecular (7.9%), POC/POL testing (7.0%), Hematology (6.3%), Anatomic Pathology (6.2%) and Immunoassay (5.9%).

    By application, the IVD market can be divided into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS. Of these, infectious diseases, followed by HIV/AIDS testing are top two generators of revenue in the market currently and are expected to maintain their positions.

    By end user location, the vast majority of IVD testing (74%) is still performed in central laboratories, defined as hospital labs, private reference labs, and blood bank labs. An increasing proportion is being performed at point-of-care locations in hospitals as well as physician offices and other decentralized sites such as retail and community clinics (11%). Finally, consumer testing – either physician directed or Over-the-Counter (OTC) – represents 15% of the IVD market.

    Experts from Frost & Sullivan have given following key drivers and restraints for global IVD market in recent years:

    For IVD industry trends in the following years, we could expect IVD market will booming in Asia Pacific region and emerging markets. Infectious diseases and HIV/AIDS testing are attracting more priority. And molecular diagnostics and POCT segment will have faster growing rates. Diagnostic testing will continue to move towards decentralization.

    IVD Industry is a very huge attractive growing pie for all stakeholders, especially in emerging markets. SZ&W Group will commit to create commercial opportunities to our members to booming IVD business in emerging markets.

     
     
          Brand Events
     
















     
    Follow us  
    Twitter
    Facebook
    Linked in
    fifa07霍芬海姆补丁
     
    © CopyRight by SZ&W|GROUP 2001-2018 沪ICP备19024769号-1
  • 迷你书屋,让阅读无处不在 2019-09-24
  • 紫光阁中共中央国家机关工作委员会 2019-09-24
  • 三星A6A6+曝光:搭载Exynos 7870+安卓8.0系统 2019-08-27
  • 人民的需要与发展的不平衡的矛盾,社会主义追求公平正义的要求与现有的发展方式、分配方式的矛 盾不断加大,必须用马克思主义政治经济学来研究解决。 2019-08-27
  • 古天乐力压刘德华 首度斩获香港电影金像奖最佳男主角 2019-08-22
  • 神奇!这种纸能千年不腐 默默记录西藏 2019-08-19
  • 世界杯冷门为何这么多? 2019-08-19
  • 对话王菊:别人谈论的王菊,是不是真实的我? 2019-08-15
  • [微笑]正是因为土地是属于全民的,你个人要使用就必须付钱,不然就占了大家的便宜。 2019-08-15
  • 包赢pk10精准计划群 闯天下精准三肖6码网站 双色球复式兑奖图表 京东小店加盟条件 90比分网即时比分 乐8电玩城 pk10如何学会看走势 福彩3d软件免费下载 单双大小如何压才稳赚 二十一点单机游戏 时时彩6码5期倍投方案 贝斯特全球最奢游戏手机app 11选5胆拖投注计划表 有欢乐生肖奖怎么玩 重庆龙虎和走势图计划 内蒙古时时